Receptor-targeted quantum dots: Fluorescent probes for brain tumor diagnosis

Journal of Biomedical Optics

Volumn 12, Issue 4, 2007, Pages

  Wang, Jingjing ^a   Yong, William H ^b   Sun, Yinghua ^b   Vernier, P Thomas ^c   Koeffler, H Phillip ^d   Gundersen, Martin A ^a   Marcu, Laura ^e  

^a Department of Biomedical Engineering ^*  (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d CEDARS SINAI MEDICAL CENTER   (United States)

^e University of California   (United States)

Author keywords

Brain tumors; Epidermal growth factor receptor; Fluorescent nanoparticles; Gliomas; Optical imaging; Quantum dots

Indexed keywords

CELLS; DIAGNOSIS; FLUORESCENCE; MEDICAL IMAGING; PROBES; TISSUE; TUMORS;

BRAIN TUMOR DIAGNOSIS; EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR); FLUORESCENT PROBES; GLIOMAS; OPTICAL IMAGING; RECEPTOR-TARGETED QUANTUM DOTS;

BRAIN;

DIAGNOSTIC AGENT; EPIDERMAL GROWTH FACTOR; FLUORESCENT DYE; QUANTUM DOT; TUMOR MARKER;

ARTICLE; BRAIN TUMOR; DRUG DELIVERY SYSTEM; FLUORESCENCE MICROSCOPY; HUMAN; METABOLISM; METHODOLOGY;

BRAIN NEOPLASMS; DRUG DELIVERY SYSTEMS; EPIDERMAL GROWTH FACTOR; FLUORESCENT DYES; HUMANS; MICROSCOPY, FLUORESCENCE; QUANTUM DOTS; TUMOR MARKERS, BIOLOGICAL;

EID: 35948956704     PISSN: 10833668     EISSN: 15602281     Source Type: Journal    
DOI: 10.1117/1.2764463     Document Type: Article

References (44)

1. T. S. Quang and L. W. Brady, "Radioimmunotherapy as a novel treatment regimen: 125I-labeled monoclonal antibody 425 in the treatment of high-grade brain gliomas," Int. J. Radiat. Oncol., Biol., Phys. 58, 972-975 (2004). (Pubitemid 38221158)
2. K. R. Hess, "Extent of resection as a prognostic variable in the treatment of gliomas," J. Neuro-Oncol. 42, 227-231 (1999). (Pubitemid 29322199)
3. N. L. Dorward, O. Alberti, B. Velani, F. A. Gerritsen, W. F. Harkness, N. D. Kitchen, and D. G. Thomas, "Postimaging brain distortion: magnitude, correlates, and impact on neuronavigation," J. Neurosurg. 88, 656-662 (1998). (Pubitemid 28145208)
4. D. L. Hill, C. R. Maurer, Jr., R. J. Maciunas, J. A. Barwise, J. M. Fitzpatrick, and M. Y. Wang, "Measurement of intraoperative brain surface deformation under a craniotomy," Neurosurgery 43, 514-526 (1998). (Pubitemid 28400123)
5. P. S. Mischel and T. Cloughesy, "Using molecular information to guide brain tumor therapy," Nat. Clin. Pract. Neurol. 2, 232-233 (2006).
6. M. E. Halatsch, U. Schmidt, J. Behnke-Mursch, A. Unterberg, and C. R. Wirtz, "Epidermal growth factor receptor inhibition for the treatment of glioblastoma multiforme and other malignant brain tumors," Cancer Treat Rev. 32, 74-89 (2006). (Pubitemid 43362229)
7. R. D. Rao and C. D. James, "Altered molecular pathways in gliomas: an overview of clinically relevant issues," Semin. Oncol. 31, 595-604 (2004). (Pubitemid 39389011)
8. D. A. Haas-Kogan, M. D. Prados, K. R. Lamborn, T. Tihan, M. S. Berger, and D. Stokoe, "Biomarkers to predict response to epidermal growth factor receptor inhibitors," Cell Cycle 4, 1369-1372 (2005). (Pubitemid 41437124)
9. X. Gao, L. Yang, J. A. Petros, F. F. Marshall, J. W. Simons, and S. Nie, "In vivo molecular and cellular imaging with quantum dots," Curr. Opin. Biotechnol. 16, 63-72 (2005). (Pubitemid 40249760)
10. X. Gao, Y. Cui, R. M. Levenson, L. W. Chung, and S. Nie, "In vivo cancer targeting and imaging with semiconductor quantum dots," Nat. Biotechnol. 22, 969-976 (2004). (Pubitemid 39014473)
11. J. K. Jaiswal, H. Mattoussi, J. M. Mauro, and S. M. Simon, "Longterm multiple color imaging of live cells using quantum dot bioconjugates," Nat. Biotechnol. 21, 47-51 (2003). (Pubitemid 36055826)
12. D. S. Lidke, P. Nagy, R. Heintzmann, D. J. Arndt-Jovin, J. N. Post, H. E. Grecco, E. A. Jares-Erijman, and T. M. Jovin, "Quantum dot ligands provide new insights into erbB/HER receptor-mediated signal transduction," Nat. Biotechnol. 22, 198-203 (2004). (Pubitemid 38160535)
13. S. Kim, Y. T. Lim, E. G. Soltesz, A. M. De Grand, J. Lee, A. Nakayama, J. A. Parker, T. Mihaljevic, R. G. Laurence, D. M. Dor, L. H. Cohn, M. G. Bawendi, and J. V. Frangioni, "Near-infrared fluorescent type II quantum dots for sentinel lymph node mapping," Nat. Biotechnol. 22, 93-97 (2004). (Pubitemid 38057962)
14. Y. T. Lim, S. Kim, A. Nakayama, N. E. Stott, M. G. Bawendi, and J. V. Frangioni, "Selection of quantum dot wavelengths for biomedical assays and imaging," Mol. Imaging 2, 50-64 (2003).
15. X. Wu, H. Liu, J. Liu, K. N. Haley, J. A. Treadway, J. P. Larson, N. Ge, F. Peale, and M. P. Bruchez, "Immunofluorescent labeling of cancer marker Her2 and other cellular targets with semiconductor quantum dots," Nat. Biotechnol. 21, 41-46 (2003). (Pubitemid 36055825)
16. D. L. Nida, M. S. Rahman, K. D. Carlson, R. Richards-Kortum, and M. Follen, "Fluorescent nanocrystals for use in early cervical cancer detection," Gynecol. Oncol. 99, 89-94 (2005).
17. M. E. Akerman, W. C. Chan, P. Laakkonen, S. N. Bhatia, and E. Ruoslahti, "Nanocrystal targeting in vivo," Proc. Natl. Acad. Sci. U.S.A. 99, 12617-12621 (2002).
18. C. Thomas, G. Ely, C. D. James, R. Jenkins, M. Kastan, A. Jedlicka, P. Burger, and R. Wharen, "Glioblastoma-related gene mutations and over-expression of functional epidermal growth factor receptors in SKMG-3 glioma cells," Acta Neuropathol. (Berl) 101, 605-615 (2001). (Pubitemid 32684760)
19. N. E. Davidson, E. P. Gelmann, M. E. Lippman, and R. B. Dickson, "Epidermal growth factor receptor gene expression in estrogen receptor-positive and negative human breast cancer cell lines," Mol. Endocrinol. 1, 216-223 (1987).
20. M. M. Haglund, M. S. Berger, and D. W. Hochman, "Enhanced optical imaging of human gliomas and tumor margins," Neurosurgery 38, 308-317 (1996). (Pubitemid 26030710)
21. T. Ichioka, S. Miyatake, N. Asai, Y. Kajimoto, T. Nakagawa, H. Hayashi, and T. Kuroiwa, "Enhanced detection of malignant glioma xenograft by fluorescein-human serum albumin conjugate," J. Neuro-Oncol. 67, 47-52 (2004). (Pubitemid 38418248)
22. W. Stummer, S. Stocker, S. Wagner, H. Stepp, C. Fritsch, C. Goetz, A. E. Goetz, R. Kiefmann, and H. J. Reulen, "Intraoperative detection of malignant gliomas by 5-aminolevulinic acid-induced porphyrin fluorescence," Neurosurgery 42, 518-525 (1998).
23. O. Veiseh, C. Sun, J. Gunn, N. Kohler, P. Gabikian, D. Lee, N. Bhattarai, R. Ellenbogen, R. Sze, A. Hallahan, J. Olson, and M. Zhang, "Optical and MRI multifunctional nanoprobe for targeting gliomas," Nano Lett. 5, 1003-1008 (2005). (Pubitemid 40925409)
24. R. Trehin, J. L. Figueiredo, M. Pittet, R. Weissleder, L. Josephson, and U. Mahmood, "Fluorescent nanoparticle uptake for brain tumor visualization," Neoplasia 8, 302-311 (2006).
25. S. A. Toms, H. Daneshvar, O. Muhammad, H. Jackson, M. A. Vogelbaum, and M. Bruchez, "Optical detection of brain tumors using quantum dots," Proc. SPIE 6009, 125-134 (2005).
26. J. Wang, P. T. Vernier, Y. Sun, M. A. Gundersen, and L. Marcu, "A fluorescence microscopy study of quantum dots as fluorescent probes for brain tumor diagnosis," Proc. SPIE 5703, 127-134 (2005). (Pubitemid 41091479)
27. W. J. Mulder, R. Koole, R. J. Brandwijk, G. Storm, P. T. Chin, G. J. Strijkers, C. M. Donega, K. Nicolay, and A. W. Griffioen, "Quantum dots with a paramagnetic coating as a bimodal molecular imaging probe," Nano Lett. 6, 1-6 (2006). (Pubitemid 43166093)
28. S. A. Toms, W. C. Lin, R. J. Weil, M. D. Johnson, E. D. Jansen, and A. Mahadevan-Jansen, "Intraoperative optical spectroscopy identifies infiltrating glioma margins with high sensitivity," Neurosurgery 57, 382-391 (2005).
29. A. Nath, K. Rivoire, S. Chang, L. West, S. B. Cantor, K. Basen-Engquist, K. Adler-Storthz, D. D. Cox, E. N. Atkinson, G. Staerkel, C. MacAulay, R. Richards-Kortum, and M. Follen, "A pilot study for a screening trial of cervical fluorescence spectroscopy," Int. J. Gynecol. Cancer 14, 1097-1107 (2004). (Pubitemid 39603352)
30. M. G. Muller, T. A. Valdez, I. Georgakoudi, V. Backman, C. Fuentes, S. Kabani, S. N. Laver, Z. Wang, C. W. Boone, R. R. Dasari, S. M. Shapshay, and M. S. Feld, "Spectroscopic detection and evaluation of morphologic and biochemical changes in early human oral carcinoma," Cancer 97, 1681-1692 (2003). (Pubitemid 36350711)
31. M. Mary-Ann and P. W. Brian, Handbook of Biomedical Fluorescence, Marcel Dekker Inc., New York (2003).
32. A. C. Croce, S. Fiorani, D. Locatelli, R. Nano, M. Ceroni, F. Tancioni, E. Giombelli, E. Benericetti, and G. Bottiroli, "Diagnostic potential of autofluorescence for an assisted intraoperative delineation of glioblastoma resection margins," Photochem. Photobiol. 77, 309-318 (2003).
33. L. Marcu, J. A. Jo, P. V. Butte, W. H. Yong, B. K. Pikul, K. L. Black, and R. C. Thompson, "Fluorescence lifetime spectroscopy of glioblastoma multiforme," Photochem. Photobiol. 80, 98-103 (2004).
34. W. H. Yong, P. V. Butte, B. K. Pikul, J. A. Jo, Q. Fang, T. Papaioannou, K. Black, and L. Marcu, "Distinction of brain tissue, low grade and high grade glioma with time-resolved fluorescence spectroscopy," Front. Biosci. 11, 1255-1263 (2006). (Pubitemid 43253417)
35. A. Bogaards, A. Varma, K. Zhang, D. Zach, S. K. Bisland, E. H. Moriyama, L. Lilge, P. J. Muller, and B. C. Wilson, "Fluorescence image-guided brain tumour resection with adjuvant metronomic photodynamic therapy: pre-clinical model and technology development," Photochem. Photobiol. Sci. 4, 438-442 (2005). (Pubitemid 40740489)
36. T. Glanzmann, J. P. Ballini, H. Bergh, and G. Wagnieres, "Timeresolved spectrofluorometer for clinical tissue characterization during endoscopy," Rev. Sci. Instrum. 70, 4067-4077 (1999). (Pubitemid 129589052)
37. F. Pinaud, X. Michalet, L. A. Bentolila, J. M. Tsay, S. Doose, J. J. Li, G. Iyer, and S. Weiss, "Advances in fluorescence imaging with quantum dot bio-probes," Biomaterials 27, 1679-1687 (2006). (Pubitemid 41759461)
38. I. L. Medintz, H. T. Uyeda, E. R. Goldman, and H. Mattoussi, "Quantum dot bioconjugates for imaging, labelling and sensing," Nat. Mater. 4, 435-446 (2005). (Pubitemid 40774047)
39. E. B. Garon, L. Marcu, Q. Luong, O. Tcherniantchouk, G. M. Crooks, and H. P. Koeffler, "Quantum dot labeling and tracking of human leukemic, bone marrow and cord blood cells," Leuk. Res. 31, 643-651 (2007). (Pubitemid 46578146)
40. A. Hara, N. Sakai, H. Yamada, S. Niikawa, T. Ohno, T. Tanaka, and H. Mori, "Proliferative assessment of GFAP-positive and GFAPnegative glioma cells by nucleolar organizer region staining," Surg. Neurol. 36, 190-194 (1991).
41. I. K. Mellinghoff, M. Y. Wang, I. Vivanco, D. A. Haas-Kogan, S. Zhu, E. Q. Dia, K. V. Lu, K. Yoshimoto, J. H. Huang, D. J. Chute, B. L. Riggs, S. Horvath, L. M. Liau, W. K. Cavenee, P. N. Rao, R. Beroukhim, T. C. Peck, J. C. Lee, W. R. Sellers, D. Stokoe, M. Prados, T. F. Cloughesy, C. L. Sawyers, and P. S. Mischel, "Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors," N. Engl. J. Med. 353, 2012-2024 (2005). (Pubitemid 41609094)
42. H. S. Friedman, R. E. McLendon, T. Kerby, M. Dugan, S. H. Bigner, A. J. Henry, D. M. Ashley, J. Krischer, S. Lovell, K. Rasheed, F. Marchev, A. J. Seman, I. Cokgor, J. Rich, E. Stewart, O. M. Colvin, J. M. Provenzale, D. D. Bigner, M. M. Haglund, A. H. Friedman, and P. L. Modrich, "DNA mismatch repair and O6-alkylguanine-DNA alkyltransferase analysis and response to temozolomide in newly diagnosed malignant glioma," J. Clin. Oncol. 16, 3851-3857 (1998). (Pubitemid 29001538)
43. A. M. Smith, S. Dave, S. Nie, L. True, and X. Gao, "Emerging implications of nanotechnology on cancer diagnostics and therapeutics," Cancer 107, 459-466 (2006).
44. P. L. Scott, C. Y. Liu, and M. L. Apuzzo, "Toward the emergence of nanoneurosurgery: Part III-nanomedicine: targeted nanotherapy, nanosurgery, and progress toward the realization of nanoneurosurgery," Neurosurgery 58, 1009-1026 (2006).